Over the past few months, advertisements for the weight-loss drug retatrutide, also known as “Reta” or “GLP-3,” have proliferated on social media and online platforms. Despite persuasive marketing and personal testimonials, consumers should be aware that retatrutide is not approved by the U.S. Food and Drug Administration (FDA) for human use, and sellers operating through unregulated channels are breaking the law.
Retatrutide is an investigational product still undergoing controlled clinical trials. It has not received approval from the FDA or any other regulatory body worldwide, meaning it cannot be legally sold to consumers. Yet online sellers, telehealth providers, and compounders are using deceptive advertising to market illegal powders, vials, and injectables that put public health at risk. Some label their products as “research-grade” to imply legitimacy, but this designation indicates the product is intended for laboratory experiments, not human consumption. Others use scientific and medical jargon to create a false sense of safety, even though these products have never undergone clinical trials or been proven safe and effective.
Because these sellers operate illegally, consumers have no reliable way to verify the products’ origin, manufacturing processes, or dosage accuracy. The products may be mislabeled, contaminated, incorrectly dosed, or contain entirely different chemicals than advertised. This has led to severe patient safety concerns. Since the beginning of 2026, poison control center reports involving illegal retatrutide have increased by 265 percent compared to the final four months of 2025. Some patients have been hospitalized after taking black-market retatrutide, including several who were hospitalized after using a potentially contaminated batch.
The rise of online marketplaces and wellness platforms has made it increasingly difficult for consumers to distinguish safe, approved medications from dangerous counterfeits. A survey by the ASOP Global Foundation found that 65 percent of Americans falsely believe all online pharmacies or health-service websites are reviewed or approved by the FDA or state regulators, and 51 percent incorrectly believe that only safe sellers appear on the first page of search results.
To avoid falling victim to illegal and unsafe products, consumers should take the following precautions: verify online pharmacies through trusted resources such as Safe Pharmacy or LegitScript, avoid any website offering medicines without a prescription, especially unapproved drugs, and obtain prescriptions from licensed healthcare providers. Patients should never have to wonder whether they are receiving genuine medication. Awareness is the first line of defense, and consumers are encouraged to push platforms, regulators, and policymakers to prevent illegal sellers from hiding behind search rankings, social media ads, and polished websites.
